Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,901
Structure and function of the brain serotonin system
Jacobs, B. L., & Azmitia, E. C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.165 · Cited by 2,576
Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Van Gompel, P., Lesage, A. S., De Loore, K., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167
The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia
Meltzer, H. Y., & McGurk, S. R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033376 · Cited by 1,020
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 1×
“In the third study, the 5-HT2A agonist psilocybin (Vollenweider et al. 1998) was administered to 18 healthy volunteers.”
BackgroundAripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 968
Self-citationOne hundred years of schizophrenia: a meta-analysis of the outcome literature
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1409 · Cited by 762
Leucht, S., Wahlbeck, K., Hamann, J., & Kissling, W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13306-5 · Cited by 725
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Glennon, R. A., Titeler, M., & McKenney, J. D. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90436-3 · Cited by 631
Araneda, R., & Andrade, R. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90128-b · Cited by 625
A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS
Woolley, D. W., & Shaw, E. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.4.228 · Cited by 602
Choudhary, M. S., Craigo, S., Sibley, D. R., Roth, B. L., Monsma, F. J., Shen, Y., Uluer, A., & Meltzer, H. Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/74zp-ze10 · Cited by 592
Self-citationJakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536
AGHAJANIAN, G. K., & MAREK, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 514
Azmitia, E. C. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00614-1 · Cited by 497 · cited 2×
“Excellent reviews on the serotonergic neuronal system have appeared (Jacobs and Azmitia 1992; Azmitia 2001), so this information will not be reiterated here.”
BackgroundMultiplicity of mechanisms of serotonin receptor signal transduction
Raymond, J. R., Mukhin, Y. V., Gelasco, A., Turner, J., Collinsworth, G., Gettys, T. W., Grewal, J. S., & Garnovskaya, M. N. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00169-3 · Cited by 466
Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor
Kohen, R., Metcalf, M. A., Khan, N., Druck, T., Huebner, K., Lachowicz, J. E., Meltzer, H. Y., Sibley, D. R., Roth, B. L., & Hamblin, M. W. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010047.x · Cited by 377
Self-citationThe Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?
Roth, B. L., Lopez, E., Patel, S., & Kroeze, W. K. (2000) · The Neuroscientist · doi:10.1177/107385840000600408 · Cited by 358
Self-citationSerotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex
Willins, D. L., Deutch, A. Y., & Roth, B. L. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199709)27:1<79::aid-syn8>3.0.co;2-a · Cited by 345
Self-citationMartı́n-Ruiz, R., Puig, M. V., Celada, P., Shapiro, D. A., Roth, B. L., Mengod, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09856.2001 · Cited by 339
Self-citationThe Physiological Role of 5-HT2AReceptors in Working Memory
Williams, G. V., Rao, S. G., & Goldman-Rakic, P. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02843.2002 · Cited by 311 · cited 2×
“…for cognitive enhancement in schizophrenia and related disorders 5-HT2A receptors are highly concentrated in cortical layer V pyramidal neurons (Willins et al. 1997) where they may be involved in integrating cognitive and perceptual information from many diverse cortical and subcortical…”
BackgroundCellular localization of the 5-HT receptor in primate brain neurons and glial cells
AZMITIA, E., GANNON, P., KHECK, N., & WHITAKERAZINITIA, P. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)80057-1 · Cited by 305
DRUGS WHICH ANTAGONIZE 5‐HYDROXYTRYPTAMINE
GADDUM, J. H., & HAMEED, K. A. (1954) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1954.tb00848.x · Cited by 293
Molecular Biology of Serotonin Receptors - Structure and Function at the Molecular Level
Kroeze, W., Kristiansen, K., & Roth, B. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023393796 · Cited by 277
Self-citationChen, A., Muzzio, I. A., Malleret, G., Bartsch, D., Verbitsky, M., Pavlidis, P., Yonan, A. L., Vronskaya, S., Grody, M. B., Cepeda, I., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00501-4 · Cited by 275
Do Specific Neurocognitive Deficits Predict Specific Domains of Community Function in Schizophrenia?
VELLIGAN, D. I., BOW-THOMAS, C. C., MAHURIN, R. K., MILLER, A. L., & HALGUNSETH, L. C. (2000) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200008000-00007 · Cited by 247
Winstanley, C. A., Chudasama, Y., Dalley, J. W., Theobald, D. E. H., Glennon, J. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1398-x · Cited by 234 · cited 2×
“Additionally, Wooley and Shaw (1954) and Gaddum and Hameed (1954) independently proposed that drugs that target the serotonergic system would be effective in treating schizophrenia.”
BackgroundBalschun, D., Wolfer, D. P., Gass, P., Mantamadiotis, T., Welzl, H., Schütz, G., Frey, J. U., & Lipp, H.-P. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06304.2003 · Cited by 229
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study
Newman-Tancredi, A., Gavaudan, S., Conte, C., Chaput, C., Touzard, M., Verrièle, L., Audinot, V., & Millan, M. J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00483-x · Cited by 227
BindingDB (2011) · PubMed · doi:10.7270/q2154fjq · Cited by 224
Multiple Serotonin Receptors: Clinical and Experimental Aspects
Roth, B. (1994) · Annals of Clinical Psychiatry · doi:10.3109/10401239409148985 · Cited by 213
Self-citationSumiyoshi, T., Matsui, M., Nohara, S., Yamashita, I., Kurachi, M., Sumiyoshi, C., Jayathilake, K., & Meltzer, H. Y. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1722 · Cited by 207
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze
Woolley, M. L., Bentley, J. C., Sleight, A. J., Marsden, C. A., & Fone, K. C. F. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00056-9 · Cited by 206
5-Hydroxytryptamine2A Receptor Inverse Agonists as Antipsychotics
Weiner, D. M., Burstein, E. S., Nash, N., Croston, G. E., Currier, E. A., Vanover, K. E., Harvey, S. C., Donohue, E., Hansen, H. C., Andersson, C. M., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29327-7 · Cited by 203
Varty, G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00072-4 · Cited by 202
Ward, R. P., Hamblin, M. W., Lachowicz, J. E., Hoffman, B. J., Sibley, D. R., & Dorsa, D. M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00439-c · Cited by 198
Riemer, C., Borroni, E., Levet-Trafit, B., Martin, J. R., Poli, S., Porter, R. H. P., & Bös, M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021085c · Cited by 197
Conn, P. J., & Sanders-Bush, E. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90017-0 · Cited by 192
Umbricht, D., Vollenweider, F. X., Schmid, L., Grübel, C., Skrabo, A., Huber, T., & Koller, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300005 · Cited by 187
霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位
Jakab, R. L., & Goldman‐Rakic, P. S. (1998) · Cited by 182
Aznar, S., Qian, Z., Shah, R., Rahbek, B., & Knudsen, G. M. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03727-7 · Cited by 180
Xia, Z., Gray, J. A., Compton-Toth, B. A., & Roth, B. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301905200 · Cited by 179
Self-citationLocalization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group
Nocjar, C., Roth, B. L., & Pehek, E. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00593-0 · Cited by 171
Self-citationWillins, D. L., Berry, S. A., Alsayegh, L., Backstrom, J. R., Sanders-Bush, E., Friedman, L., & Roth, B. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00653-8 · Cited by 171
Self-citationRoth, B. L., Nakaki, T., Chuang, D., & Costa, E. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90244-2 · Cited by 157
Self-citationThe effect of tandospirone, a serotonin1A agonist, on memory function in schizophrenia
Sumiyoshi, T., Matsui, M., Yamashita, I., Nohara, S., Kurachi, M., Uehara, T., Sumiyoshi, S., Sumiyoshi, C., & Meltzer, H. Y. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01025-8 · Cited by 154
Wilson, M. A., & Molliver, M. E. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90076-z · Cited by 152
Pehek, E. A., McFarlane, H. G., Maguschak, K. A., Price, B., & Pluto, C. P. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03004-3 · Cited by 147
Lamirault, L., & Simon, H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00123-x · Cited by 147
Dawson, L. A., Nguyen, H. Q., & Li, P. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703288 · Cited by 134
Wilson, M. A., & Molliver, M. E. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90077-2 · Cited by 133
Cognition, schizophrenia, and the atypical antipsychotic drugs
Meltzer, H. Y., Park, S., & KESSLER, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13591 · Cited by 132
Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry
Vilaró, M. T., Cortés, R., Gerald, C., Branchek, T. A., Palacios, J. M., & Mengod, G. (1996) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00248-3 · Cited by 128
Inhibitory Effect of Hippocampal 5-HT1A Receptors on Human Explicit Memory
Yasuno, F., Suhara, T., Nakayama, T., Ichimiya, T., Okubo, Y., Takano, A., Ando, T., Inoue, M., Maeda, J., & Suzuki, K. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.334 · Cited by 123
Moser, P. C., Bergis, O. E., Jegham, S., Lochead, A. W., Duconseille, E., Terranova, J.-P., Caille, D., Berque‐Bestel, I., Lezoualc’h, F., Fischmeister, R., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034249 · Cited by 116
Mapping of serotonin 5-HT4 receptor mRNA and ligand binding sites in the post-mortem human brain
Bonaventure, P., Hall, H., Gommeren, W., Cras, P., Langlois, X., Jurzak, M., & Leysen, J. E. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200004)36:1<35::aid-syn4>3.0.co;2-y · Cited by 107
Buchanan, R. W., Summerfelt, A. T., Tek, C., & Gold, J. M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00387-5 · Cited by 105
Bentley, J., Bourson, A., Boess, F., Fone, K. C. F., Marsden, C. A., Petit, N., & Sleight, A. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702445 · Cited by 105
The Human Serotonin 5-HT4 Receptor Regulates Secretion of Non-amyloidogenic Precursor Protein
Robert, S. J., Zugaza, J. L., Fischmeister, R., Gardier, A. M., & Lezoualc'h, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109008200 · Cited by 104
Lindner, M. D., Hodges, D. B., Hogan, J. B., Orie, A. F., Corsa, J. A., Barten, D. M., Polson, C. T., Robertson, B., Guss, V. L., Gillman, K. W., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056002 · Cited by 103
BIMU1 Increases Associative Memory in Rats by Activating 5-HT 4 Receptors
Marchetti, E., Roman, F. S., Dumuis, A., Bockaert, J., & Soumireu-Mourat, B. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00058-0 · Cited by 101
Xia, Z., Hufeisen, S. J., Gray, J. A., & Roth, B. L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00589-x · Cited by 95
Self-citationSchechter, L., Dawson, L., & Harder, J. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023396483 · Cited by 93
Atypical antipsychotic drug actions: unitary or multiple mechanisms for ‘atypicality’?
Roth, B. L., Sheffler, D. J., & Potkin, S. G. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00021-5 · Cited by 92
Self-citationPoyurovsky, M., Koren, D., Gonopolsky, I., Schneidman, M., Fuchs, C., Weizman, A., & Weizman, R. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00155-4 · Cited by 90
Terry, A. V., Buccafusco, J. J., Jackson, W. J., Prendergast, M., Fontana, D. J., Wong, E. H. F., Bonhaus, D. W., Weller, P. E., & Eglen, R. M. (1998) · Psychopharmacology · doi:10.1007/s002130050529 · Cited by 83
Clozapine—A serotonin antagonist?
Fink, H., Morgenstern, R., & Oelssner, W. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90297-1 · Cited by 80
Green, M. F., & BRAFF, D. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01027-1 · Cited by 79
Carlsson, M. L., Martin, P., Nilsson, M., Sorensen, S. M., Carlsson, A., Waters, N., & Waters, N. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050144 · Cited by 78
Vilaró, M. T., Domènech, T., Palacios, J. M., & Mengod, G. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00154-x · Cited by 78
Chronic clozapine treatment of rats down-regulates cortical 5-HT2 receptors
Reynolds, G. P., Garrett, N. J., Rupniak, N. M. J., Jenner, P. G., & MARSDEN, C. D. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90517-4 · Cited by 76
5HT Antagonists Attenuate MK801-Impaired Radial Arm Maze Performance in Rats
Boast, C. A., Bartolomeo, A. C., Morris, H., & Moyer, J. A. (1999) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1998.3886 · Cited by 72
Velligan, D. I., & Miller, A. L. (1999) · PubMed · Cited by 68
Meneses, A. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1021800822997 · Cited by 57
The complexity of drug development for irritable bowel syndrome
Kamm, M. A. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01185.x · Cited by 54
Lamirault, L., Guillou, C., Thal, C., & Simon, H. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00351-2 · Cited by 47
Purohit, A., Herrick‐Davis, K., & Teitler, M. (2002) · Synapse · doi:10.1002/syn.10157 · Cited by 38
Dual effects of 5-HT4 receptor activation on GABA release from guinea pig hippocampal slices
Bianchi, C., Rodi, D., Marino, S., Beani, L., & Siniscalchi, A. (2002) · Neuroreport · doi:10.1097/00001756-200212030-00003 · Cited by 35
Minabe, Y., Hashimoto, K., Watanabe, K., & Ashby, C. R. (2001) · Synapse · doi:10.1002/syn.1031 · Cited by 31
Roth, B. L., Willins, D. L., Kristiansen, K., & Kroeze, W. K. (1999) · The Neuroscientist · doi:10.1177/107385849900500414 · Cited by 31
Self-citationRényi, L., Evenden, J. L., Fowler, C. J., Jerning, E., Kelder, D., Lake‐Bakaar, D. M., Larsson, L.-G., Mohell, N., Sällemark, M., & Ross, S. B. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29206-5 · Cited by 13
Cited by
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
Self-citationMiyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Structural Basis for Molecular Recognition at Serotonin Receptors
Wang, C., Jiang, Y., Ma, J., Wu, H., Wacker, D., Katritch, V., Han, G. W., Liu, W., Huang, X.-P., Vardy, E., et al. (2013) · Science · doi:10.1126/science.1232807 · Cited by 528
Self-citationAsenapine: a novel psychopharmacologic agent with a unique human receptor signature
Shahid, M., Walker, G., Zorn, S., & Wong, E. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881107082944 · Cited by 493
Metadata
- Authors
- Roth, B., Hanizavareh, S. M., & Blum, A.
- Venue
- Psychopharmacology
- Published
- 2003-12-02
- Volume
- 174
- Issue
- 1
- Pages
- 17-24
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2077604455
- Cited by
- 257
- References
- 83
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.